Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Trimeris cheered by Q2 Fuzeon sales
Net sales of Fuzeon in the US and Canada for the second quarter of 2006 were $31.1 million, an increase of 23% over Q2 2005. Total worldwide net
Net sales of Fuzeon in the US and Canada for the second quarter of 2006 were $31.1 million, an increase of 23% over Q2 2005. Total worldwide net
The company in question, BioEden is registered with the FDA and claims to be the first tooth cell bank in the world to offer cellular isolation and storage
Professor Ashley Bush, of the Mental Health Research Institute of Victoria, Australia and co-founding scientist of Prana, presented data on PBT2 at the 10th International Conference on Alzheimer’s
A special protocol assessment (SPA) provides a mechanism for the FDA and sponsors to reach agreement on the design, size, execution and analysis of a clinical trial that
These compounds effectively inhibit JAK3 (janus kinase 3) dependent lymphocyte proliferation and are highly selective in an array of off-target assays. The compounds were discovered and characterized by
This is the first microbicide clinical development program specifically for prevention of genital herpes to be funded by the US National Institutes of Health (NIH). Starpharma also understands
IT-101 is a combination of Insert’s patented polymer technology, Cyclosert, and the anticancer compound camptothecin. According to the company, Cyclosert is the first nanoparticulate drug delivery platform to
The data suggest that study participants taking 800mg of Flurizan demonstrated a substantial benefit over other dose groups in the study and that this benefit continued to increase
BioWisdom’s intelligence networks are codified knowledge drawn from diverse information taken from public, third party and in-house sources. “We have been working with BioWisdom for the past two
Chronic pain affects approximately 48 million people in the US and current medications are either largely ineffective or have serious side effects. Most prior attempts at alleviating chronic